Extracorporeal Membrane Oxygenation for Bridge to Decision and to Recovery Shigeki Tabata, Hitoshi Hirose, Nicholas C. Cavarocchi, James T. Diehl, Hiroyuki.

Slides:



Advertisements
Similar presentations
Healing the Heart: When Failure is Not an Option
Advertisements

CASE HISTORY Yu Gang. General information Age: 13-year-old Sex: male Nationality: U.K.
Division of Congenital Cardiovascular Surgery
Research By: Dr. Ritta Baena Visual Effects By: John Baena
EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
Left ventricular thrombus and its complications during veno-arterial extracorporeal membrane oxygenation (ECMO) in a patient with acute leukemia related.
Extracorporeal Membrane Oxygenation (ECMO): Indications and Management Strategy David Spielvogel, MD Surgical Director, Cardiac Transplant and Mechanical.
Acute Respiratory Distress Syndrome(ARDS)
Intra-aortic Balloon Pump (IABP)
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
Hemolysis in Patients Supported with Durable, Long-Term Left Ventricular Assist Device Therapy Jason N. Katz, MD,MHS; Brian C. Jensen, MD; Patricia P.
Innovative Minimally Invasive Circulatory Assist Device.
Extracorporeal Membrane Oxygenation Following Lung Transplantation in Adult ISKANDER AL-GITHMI, M.D., FRCSC, FRCSC (Ts & CDs), FCCP. Assistant Professor.
MRSA sepsis and ARDS; Is it an indication for ECMO? Philip Hsiao BS, Joseph Miessau MS, Harrison Pitcher MD, Qiong Yang MD, Michael Baram MD, Nicholas.
Defibrillation 4/19/2017
Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Ventricular Assist Devices Brian Schwartz, CCP February 25, 2003.
Rejection Normal response Inflammation 25% of pt. will have acute rejection during the first year post transplant Causes: Previous Rejection Noncompliance.
Introduction to Ventricular Assist Device (VAD)
Biventricular Failure – Total Artificial Heart Francisco A. Arabía, MD Director, CHSI Center for Surgical Device Management Cedars-Sinai Heart Institute.
Unsettled and Unanswered Questions Christopher Caldarone AATS symposium April 26 th, 2015.
What is it? What are my responsibilities as baby nurse?
Extracorporeal Membrane Oxygenation
Collaborating for Life: The Organ and Tissue Donation Process Presented by: Liz Lowry, Hospital Services Coordinator.
Ventricular Assist Devices A Ventricular assist device, or VAD, is a mechanical circulatory device that is used to partially or completely replace the.
Optimal Therapies for End-Stage Thoracic Organ Failure: The Critical Role of the Surgeon and the Use of ECMO, MCS and Transplantation Decision Making:
Acute Kidney Injury requiring renal replacement therapy increases mortality in patients undergoing Extracorporeal Membrane Oxygenation therapy. Divisions.
Early Mobilization of LVAD Recipients Christiane S. Perme, PT, Robert E. Southard, MD, David L Joyce, MD George P Noon, MD, Matthias Loebe, MD, PhD Tex.
Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children’s.
Respiratory Respiratory Failure and ARDS. Normal Respirations.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
Mechanical Circulatory Support Cardiogenic Shock Post AMI
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
Is the failure of pulmonary gas exchange to maintain the normal arterial O2 and CO2 level. It is divided in to type I and II in relation to the presence.
CARDIOHELP TRAINING June 18-19, 2013
1 Shock. 2 Shock refers to an abnormality of the circulatory system in which there is inadequate tissue perfusion due to a relatively or absolutely inadequate.
Cardiovascular Therapeutic Management 2013
Presented by Nai-Hsin Chi National Taiwan University Hospital
E XTRACORPOREAL M EMBRANE O XYGENATION IN A WAKE P ATIENTS AS B RIDGE TO L UNG T RANSPLANTATION Am J Respir Crit Care Med 2012;185(7):763–8. R3 이민혜 Thomas.
ECMO Extracorporeal membrane oxygenation
ATRIAL ESOPHAGEAL FISTULA SECONDARY TO ABLATION FOR ATRIAL FIBRILLATION: A CASE SERIES AND REVIEW OF THE LITERATURE 1 Lily K. Fatula, BS; 1,2 William D.
Defibrillation 10/24/2017
Review of the Toxicology Investigators Consortium (ToxIC)
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
University of Chicago Medicine
Ventricular Assist Device
Ventricular function recovery on LVAD For idiopathic or ischemic CM
Preoperative screening for LVAD an TAH implantation
Assist Devices for the Treatment of Cardiogenic Shock
PEA arrest: Chest compressions aren’t enough
Role of ECMO in Acute Cardiogenic Shock
Mechanical circulatory support
Miniaturized hemodynamic transesophageal echocardiogram (hTEE) can accurately diagnose pericardial tamponade after open-heart surgery Shreya Gupta, BS.
Cardiac arrest & Reactivation
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
ECMO and advanced intensive care Euro-Elso 2013
Extracorporeal Life Support (ECLS)
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Hemodynamic and physiologic changes during support with an implantable left ventricular assist device  Patrick M. McCarthy, MD (by invitation), Robert.
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Pediatric Respiratory
Weaning of extracorporeal membrane oxygenation using continuous hemodynamic transesophageal echocardiography  Nicholas C. Cavarocchi, MD, Harrison T.
ΝΟΣΟΣ ΤΑΧΥΒΡΑΔΥΚΑΡΔΙΑΣ: ΕΜΦΥΤΕΥΣΗ ΒΗΜΑΤΟΔΟΤΗ Η ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ; ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΕΠ.Α ΚΑΡΔΙΟΛΟΓΟΣ ΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ.
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
Comparative Effects of Ventricular Assist Device and Extracorporeal Membrane Oxygenation on Renal Function in Pediatric Heart Failure  Parthak Prodhan,
Michiaki Imamura, MD, PhD, Amy M
Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival  Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.
Long-term survival after pediatric cardiac transplantation and postoperative ECMO support  Kathleen N Fenton, MD, Steven A Webber, MD, David A Danford,
Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K
Presentation transcript:

Extracorporeal Membrane Oxygenation for Bridge to Decision and to Recovery Shigeki Tabata, Hitoshi Hirose, Nicholas C. Cavarocchi, James T. Diehl, Hiroyuki Abe Thomas Jefferson University, Philadelphia, PA

【 Objective 】 The indications for extracorporeal membrane oxygenation (ECMO) therapy have since grown to encompass both respiratory and cardiac failure and are now being increasingly used in adult patients. We report a patient who traveled from India to the USA and developed acute decompensated biventricular failure and shock requiring ECMO placement as a bridge to decision.

【 Case presentation-1 】 A 66-year-old female who traveled from India to the US presented with severe heart failure and was placed on V-A ECMO for bridge to decision.

【 Chest X-ray before ECMO placement 】 Acute pulmonary edema secondary to severe heart failure

【 Case presentation-2 】 During the first 36 hours the patient lost intrinsic cardiac rhythm while on ECMO. On ECMO day 4, a temporary transvenous endocardial pacing wire was inserted without capture despite optimal placement. Ventricular capture was regained 48 hours later.

【 Chest X-ray after pacing wire insertion 】

【 Case presentation-3 】 Multiple organ dysfunction as well as neurological status improved and were maintained by ECMO support. Further work-up indicated that the patient was not a candidate for heart transplant or permanent ventricular assist device. ECMO support was continued until there was recovery from acute decompensated of chronic heart failure.

【 Case presentation-4 】 ECMO was weaned off with appropriated pharmacological support. The patient was weaned to oral heart failure medications, discharged to a rehabilitation facility and at home in 1 month.

【 Chest X-ray at D/C 】

【 Discussion-1 】 As the technology of the ECMO circuit improved, the patient care during ECMO has focused on the end- organ recovery. During ECMO support, organs such as brain, liver, kidney, lungs, gastrointestinal tract and muscles are well perfused and the temporally malfunctioned organ due to abrupt cardiopulmonary failure will have a chance to recover. In this case, ECMO provided enough flow to vital organs, improving or maintaining end organ functions.

【 Discussion-2 】 ECMO is a temporary device and not designed for long- term use. As the patient was not a candidate for heart transplantation due to several comorbids and the patient body habitus was too small for implantable LVAD, The only option left for this patient was optimal medical treatment. We performed careful bedside ECMO weaning using TEE and successfully decannulated ECMO.

【 Conclusions 】 This is a case of ECMO support for cardiogenic shock complicated with malignant tachyarrhythmia and cardiac arrest. ECMO was able to maintain the organ perfusion without causing any complications. ECMO was removed with pharmacological support without any mechanical cardiac support.